12 months from date of receipt / reconstitution, -20 °C as supplied
应用 | 稀释度 |
---|---|
IHC-P | 1:1000 |
PAPP-A is a proteolytic enzyme that was discovered to increase local insulin-like growth factor (IGF) availability for receptor activation through cleavage of inhibitory IGF binding proteins (IGFBPs). Reduced IGF signaling has been associated with increased lifespan and healthspan.
Therefore, inhibition of PAPP-A represents a novel approach to indirectly decrease the availability of bioactive IGF [PMID: 28035757IF: 8.0 Q1 ].